Does the FDA support HRT for quality of life

DISCLOSURE: Voshell’s Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

According to FDA.gov, the FDA supports hormone therapy when it is used to relieve menopause symptoms that disrupt a woman’s daily comfort, functioning, and well‑being. According to FDA-approved prescribing information, estrogen therapy and estrogen‑progestin therapy are specifically approved for moderate to severe menopausal symptoms — all of which may affect quality of life. A qualified prescriber may determine whether treatment is appropriate for an individual patient.
Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

How the FDA Views HRT

According to FDA.gov, the FDA approves estrogen therapy and estrogen‑progestin therapy for moderate to severe menopausal symptoms. These symptoms include hot flashes, night sweats, sleep problems, vaginal dryness, painful intercourse, and urinary discomfort. All of these may have a quality‑of‑life impact. When these symptoms interfere with daily living, the FDA considers treatment medically appropriate.

According to FDA.gov, the FDA does not frame hormone therapy as a cosmetic or wellness product. Instead, it recognizes that menopause symptoms may meaningfully reduce a woman’s physical comfort, sexual health, sleep quality, and emotional well‑being. Treating these symptoms is considered a legitimate medical purpose under FDA guidance.

What "Quality of Life" Means in FDA Language

• Vasomotor symptoms: Hot flashes and night sweats that may interrupt sleep or daily activities.
• Genitourinary symptoms: Vaginal dryness, burning, or urinary discomfort that may affect intimacy or comfort.
• Sleep disruption: When menopause‑related awakenings may reduce energy, mood, or concentration.
• Emotional well‑being: Mood changes linked to untreated symptoms that may make functioning harder.

According to FDA.gov, all of these are considered legitimate medical reasons for hormone therapy under FDA guidance.

What the FDA Does Not Support

• Using hormone therapy solely for anti‑aging purposes or disease prevention (such as preventing dementia). According to FDA Drug Safety Communication, evidence does not support those uses, and FDA boxed warnings note risks including stroke, DVT, and PE.
• Using compounded hormone preparations instead of commercially available products unless medically necessary, as determined by a qualified prescriber. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing.

The Bottom Line

According to FDA.gov, you do not need extreme symptoms to qualify for consideration. If menopause changes are interfering with your comfort or daily functioning, the FDA considers commercially available hormone therapy an appropriate, supported treatment option when prescribed by a qualified prescriber. Consult a qualified prescriber to determine whether hormone therapy may be appropriate for your individual situation.